Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

Wound Care Biologics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028


Market Overview 2023-2028:

The global wound care biologics market size reached US$ 1.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 3.2 Billion by 2028, exhibiting a growth rate (CAGR) of 8.5% during 2023-2028.

Wound care biologics refer to drugs extracted or semi-synthesized from natural sources which are used for controlling and healing infections. Wound healing is a complex process involving inflammation, accumulation of fibrous tissue, deposition of collagen, formation of epithelial cell layers and other disruptions. Biologic wound healing treatments possess the ability to restore the natural repair mechanism through active biological agents. For instance, plant-derived active biomolecules with antimicrobial, anti-inflammatory or antioxidant properties have proven efficacious in advancing the wound-healing process. Some of the recent technological advancements made in the field of wound healing include skin substitutes, bio-membranes, scaffolds, hydroconductive dressings and biologics.

Chronic skin wounds can be caused due to burns, skin cancers, infections, trauma or an underlying medical condition such as diabetes. With the growing prevalence of these ailments along with the expanding geriatric population, there has been a rise in the demand for treatments that can accelerate wound healing and facilitate a speedy recovery. Along with this, several initiatives have been undertaken by governments across the globe to create awareness about the benefits of wound care biologics among patients. Apart from this, manufacturers are also developing next-generation, cost-effective and high-quality biologics to make them more accessible. Moreover, many research and healthcare centers are entering into partnerships to modernize wound care treatments and develop innovative drugs for healing wounds. For example, researchers are focusing on integrating antimicrobial compounds into the wound dressing itself. These materials combine traditional wound dressings such as hydrogels or foams with antimicrobial compounds such as betaine, silver, chitin, or polyhexamethylene biguanide.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global wound care biologics market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on product, wound type, application and end-user.

Breakup by Product:

Biologic Skin Substitutes
Human Donor Tissue-Derived Products
Acellular Animal-Derived Products
Biosynthetic Products
Topical Agents

Breakup by Wound Type:

Ulcers
Diabetic Foot Ulcers
Venous Ulcers
Pressure Ulcers
Others
Surgical and Traumatic Wounds
Burns

Breakup by Application:

Acute Wound
Chronic Wound
Surgical Wound

Breakup by End-User:

Hospitals
ASCs
Burn Centres and Wound Clinics

Breakup by Region:

Asia Pacific
Europe
North America
Middle East and Africa
Latin America

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Smith & Nephew, Mölnlycke Health Care, Integra lifesciences, Osiris Therapeutics, Avita Medical, ConvaTec Group, Cytori Therapeutics, Mylan, Johnson & Johnson, Leap Therapeutics, Nuo Therapeutics, Mallinckrodt, Wright Medical, Mimedx Group and Solsys Medical, etc.

Key Questions Answered in This Report:
How has the global wound care biologics market performed so far and how will it perform in the coming years?
What are the key regional markets in the global wound care biologics industry?
What has been the impact of COVID-19 on the global wound care biologics industry?
What is the breakup of the market based on the product?
What is the breakup of the market based on the wound type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global wound care biologics industry?
What are the key driving factors and challenges in the global wound care biologics industry?
What is the structure of the global wound care biologics industry and who are the key players?
What is the degree of competition in the global wound care biologics industry?


1 Preface
2 Scope and Methodology
2.1Objectives of the Study
2.2Stakeholders
2.3Data Sources
2.3.1Primary Sources
2.3.2Secondary Sources
2.4Market Estimation
2.4.1Bottom-Up Approach
2.4.2Top-Down Approach
2.5Forecasting Methodology
3 Executive Summary
4 Introduction
4.1Overview
4.2Key Industry Trends
5 Global Wound Care Biologics Market
5.1Market Overview
5.2Market Performance
5.3Impact of COVID-19
5.4Market Breakup by Product
5.5Market Breakup by Wound Type
5.6Market Breakup by Application
5.7Market Breakup by End-User
5.8Market Breakup by Region
5.9Market Forecast
6 Market Breakup by Product
6.1Biologic Skin Substitutes
6.1.1Market Trends
6.1.2Market Breakup by Type
6.1.2.1 Human Donor Tissue-Derived Products
6.1.2.2 Acellular Animal-Derived Products
6.1.2.3 Biosynthetic Products
6.1.3Market Forecast
6.2Topical Agents
6.2.1Market Trends
6.2.2Market Forecast
7 Market Breakup by Wound Type
7.1Ulcers
7.1.1Market Trends
7.1.2Market Breakup by Type
7.1.2.1 Diabetic Foot Ulcers
7.1.2.2 Venous Ulcers
7.1.2.3 Pressure Ulcers
7.1.2.4 Others
7.1.3Market Forecast
7.2Surgical and Traumatic Wounds
7.2.1Market Trends
7.2.2Market Forecast
7.3Burns
7.3.1Market Trends
7.3.2Market Forecast
8 Market Breakup by Application
8.1Acute Wound
8.1.1Market Trends
8.1.2Market Forecast
8.2Chronic Wound
8.2.1Market Trends
8.2.2Market Forecast
8.3Surgical Wound
8.3.1Market Trends
8.3.2Market Forecast
9 Market Breakup by End-User
9.1Hospitals
9.1.1Market Trends
9.1.2Market Forecast
9.2ASCs
9.2.1Market Trends
9.2.2Market Forecast
9.3Burn Centres and Wound Clinics
9.3.1Market Trends
9.3.2Market Forecast
10 Market Breakup by Region
10.1Asia Pacific
10.1.1Market Trends
10.1.2Market Forecast
10.2Europe
10.2.1Market Trends
10.2.2Market Forecast
10.3North America
10.3.1Market Trends
10.3.2Market Forecast
10.4Middle East and Africa
10.4.1Market Trends
10.4.2Market Forecast
10.5Latin America
10.5.1Market Trends
10.5.2Market Forecast
11 SWOT Analysis
11.1Overview
11.2Strengths
11.3Weaknesses
11.4Opportunities
11.5Threats
12 Value Chain Analysis
13 Porter’s Five Forces Analysis
13.1Overview
13.2Bargaining Power of Buyers
13.3Bargaining Power of Suppliers
13.4Degree of Competition
13.5Threat of New Entrants
13.6Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1Market Structure
15.2Key Players
15.3Profiles of Key Players
15.3.1Smith & Nephew
15.3.2Mölnlycke Health Care
15.3.3Integra lifesciences
15.3.4Osiris Therapeutics
15.3.5Avita Medical
15.3.6ConvaTec Group
15.3.7Cytori Therapeutics
15.3.8Mylan
15.3.9Johnson & Johnson
15.3.10 Leap Therapeutics
15.3.11 Nuo Therapeutics
15.3.12 Mallinckrodt
15.3.13 Wright Medical
15.3.14 Mimedx Group
15.3.15 Solsys Medical

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings